The Future of CAD/PAD Management
In this Pharmacy Times® Insights discussion, Paul Dobesh, PharmD, and James Groce III, PharmD, provide thoughts on the future of CAD/PAD management.
Advancements in CLL: Front-Line Therapy Decision Criteria
Key opinion leaders consider the decision criteria for selecting a front-line therapy for patients with chronic lymphocytic leukemia (CLL).
Pharmacy Times® interviewed Clayton Edwards, the Chief Operating Officer of AllianceRx Walgreen Prime, on the value of a pharmacist in the management of patient care.
A Coalition of Patients Urges Congress to Recognize the Importance of Pharmacists During the COVID-19 Pandemic
National Association of Chain Drug Stores joins with 20 other groups in asking Congress to take action that includes designating pharmacists as providers under Medicare.
New research indicates a need to understand the mental health impacts of the coronavirus disease 2019 pandemic.
Several recent studies presented at the virtual SGO 2020 Annual Meeting on Women’s Cancer looked into veliparib, a potential anticancer PARP inhibitor, for treatment of various types of ovarian cancer.
Helath care workers report higher levels of stress, anxiety, and fatigue, as well as reduced feelings of control over their lives, as a result of COVID-19.
By using a non-invasive screening model, care providers can help catch and treat more cases of colorectal cancer, a new study suggests.
Study examines the effect of a low-calorie, plant-based diet combined with vitamin C in helping to kill cancer cells.
Cancer care providers have increasingly been using biosimilars on a case-by-case basis with patients.
The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
There is evidence that Robert Louis Stevenson wrote Dr. Jekyll and Mr. Hyde after being prescribed cocaine. What illness were they trying to treat?
The clinical trial of teclistamab sought to identify a recommended phase 2 dose for patients with RRMM, with multiple IV doses and priming doses explored.
Mesalamine suppositories are used to treat mild to moderate ulcerative colitis.
Student Café: Impact of COVID-19 on Pharmacy Education
Pharmacy students discuss how has the coronavirus disease 2019 (COVID-19) has impacted their education and preparation for future careers.